Laman UtamaDNA • NYSE
add
Ginkgo Bioworks Holdings Inc
$9.17
Selepas Waktu Dagangan:(0.55%)+0.050
$9.22
Tutup: 16 Jun, 6:54:14 PTG GMT-4 · USD · NYSE · Penafian
Tutup sebelumnya
$8.94
Julat hari
$8.63 - $9.34
Julat tahun
$5.00 - $18.55
Permodalan pasaran
509.23J USD
Bilangan Purata
1.10J
Nisbah P/E
-
Hasil dividen
-
Pertukaran utama
NYSE
Dalam berita
Kewangan
Penyata Pendapatan
Hasil
Pendapatan bersih
| (USD) | Mac 2025info | Perubahan T/T |
|---|---|---|
Hasil | 48.32J | 27.34% |
Perbelanjaan pengendalian | 124.26J | -39.31% |
Pendapatan bersih | -90.96J | 45.18% |
Margin untung bersih | -188.25 | 56.95% |
Pendapatan bagi setiap syer | — | — |
EBITDA | -72.62J | 55.48% |
Kadar cukai berkesan | -0.10% | — |
Kunci Kira-kira
Jumlah aset
Jumlah liabiliti
| (USD) | Mac 2025info | Perubahan T/T |
|---|---|---|
Pelaburan tunai dan jangka pendek | 516.92J | -38.49% |
Jumlah aset | 1.29B | -18.23% |
Jumlah liabiliti | 646.04J | 8.67% |
Jumlah ekuiti | 647.43J | — |
Syer tertunggak | 58.53J | — |
Harga kepada buku | 0.76 | — |
Pulangan pada aset | -16.47% | — |
Pulangan pada modal | -19.42% | — |
Aliran Tunai
Perubahan bersih dalam tunai
| (USD) | Mac 2025info | Perubahan T/T |
|---|---|---|
Pendapatan bersih | -90.96J | 45.18% |
Tunai daripada operasi | -51.52J | 42.28% |
Tunai daripada pelaburan | -198.68J | -1,540.66% |
Tunai daripada pembiayaan | -207.00K | 75.50% |
Perubahan bersih dalam tunai | -250.34J | -144.54% |
Aliran tunai bebas | 4.11J | 109.08% |
Perihal
Ginkgo Bioworks Holdings, Inc. is an American biotech company founded in 2008 by five scientists from MIT, headed by Jason Kelly. The company specializes in using genetic engineering to produce bacteria with industrial applications for other biotech companies, saving other companies the cost of reproducing the initial stages of design in synthetic biology. The self-proclaimed "Organism Company" was one of the world's largest privately held biotech companies, valued at $4.2 billion in 2019. It raised $290 million in September and $350 million in October of that year. Ginkgo Bioworks went public on the New York Stock Exchange via a SPAC merger on September 17, 2021. Wikipedia
CEO
Diasaskan
2008
Ibu pejabat
Tapak web
Pekerja
834
